Close Menu

NEW YORK – Abbott said today that it has received US Food and Drug Administration approval for use of its Alinity s System to conduct screening in US blood and plasma centers.

The system, which runs up to 600 tests per hour, has been designed to screen efficiently and within a small space, Abbott said. It added that its automation and flexibility will help blood and plasma centers improve productivity and maintain accuracy within a testing specialty that can require extensive hands-on time.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.